1,023
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Atypical Pyoderma gangrenosum: a case of delayed recognition

, , , , MD, &
Pages 242-248 | Received 01 Oct 2020, Accepted 15 Dec 2020, Published online: 23 Mar 2021

References

  • Adachi Y, Kindzelskii AL, Cookingham G, et al., Todd RF 3rd. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. Petty HRJ Invest Dermatol. 1998;111(2):259.
  • Shands JW Jr, Flowers FP, Hill HM, et al. Pyoderma gangrenosum in a kindred. Precipitation by surgery or mild physical trauma. J Am Acad Dermatol. 1987;16(5 Pt 1):931–934.
  • Wollina U. Pyoderma gangrenosum–a review. Orphanet J Rare Dis. 2007;2:19.
  • Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33(4):787–802.
  • Saffie MG, Shroff A. A case of pyoderma gangrenosum misdiagnosed as necrotizing infection: a potential diagnostic catastrophe. Case Rep Infect Dis. 2018;(2018:8907542.
  • Marinopoulos S, Theofanakis C, Zacharouli T, et al. Pyoderma Gangrenosum of the breast: A case report study. Int J Surg Case Rep. 2017;31:203–205.
  • Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008;87(5):281–293.
  • Thornton JR, Teague RH, Low-Beer TS, et al. Pyoderma gangrenosum and ulcerative colitis. Gut. 1980;21(3):247–248.
  • Maverakis EM, Ma C, Shinkai K, et al. Diagnostic criteria of ulcerative pyoderma gangrenosum a delphi consensus of international experts. JAMA Dermatol. 2018;154(4):461–466.
  • Su WP, Davis MD, Weenig RH, et al. Pyoderma gangrenosum, clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800.
  • Weenig RH, Davis MD, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412–1418.
  • Shahid S, Myszor M, De Silva A. Pyoderma gangrenosum as a first presentation of inflammatory bowel disease. BMJ Case Rep. 2014;(2014:bcr2014204853.
  • Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.
  • Ormerod AD, Thomas KS, Craig FE, et al., UK Dermatology Clinical, Trials Network’s STOP GAP Team. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015;350: h2958.
  • Patel F, Fitzmaurice S, Duong C, et al. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015;95(5):525–531.